GO:0017076 | purine nucleotide binding | 30.0% (18/60) | 2.47 | 0.0 | 0.0 |
GO:0097367 | carbohydrate derivative binding | 30.0% (18/60) | 2.42 | 0.0 | 0.0 |
GO:0032553 | ribonucleotide binding | 30.0% (18/60) | 2.43 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 45.0% (27/60) | 1.78 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 45.0% (27/60) | 1.78 | 0.0 | 0.0 |
GO:0005488 | binding | 56.67% (34/60) | 1.42 | 0.0 | 0.0 |
GO:0032555 | purine ribonucleotide binding | 30.0% (18/60) | 2.48 | 0.0 | 0.0 |
GO:0035639 | purine ribonucleoside triphosphate binding | 30.0% (18/60) | 2.5 | 0.0 | 0.0 |
GO:0030554 | adenyl nucleotide binding | 25.0% (15/60) | 2.49 | 0.0 | 1e-06 |
GO:0005524 | ATP binding | 25.0% (15/60) | 2.51 | 0.0 | 1e-06 |
GO:0032559 | adenyl ribonucleotide binding | 25.0% (15/60) | 2.49 | 0.0 | 1e-06 |
GO:1901265 | nucleoside phosphate binding | 30.0% (18/60) | 2.1 | 0.0 | 1e-06 |
GO:0000166 | nucleotide binding | 30.0% (18/60) | 2.1 | 0.0 | 1e-06 |
GO:0008144 | drug binding | 25.0% (15/60) | 2.35 | 0.0 | 2e-06 |
GO:0043168 | anion binding | 30.0% (18/60) | 2.0 | 0.0 | 3e-06 |
GO:0036094 | small molecule binding | 30.0% (18/60) | 1.98 | 0.0 | 3e-06 |
GO:0006418 | tRNA aminoacylation for protein translation | 8.33% (5/60) | 4.61 | 2e-06 | 2.1e-05 |
GO:0043039 | tRNA aminoacylation | 8.33% (5/60) | 4.44 | 3e-06 | 3.1e-05 |
GO:0043038 | amino acid activation | 8.33% (5/60) | 4.44 | 3e-06 | 3.1e-05 |
GO:0004812 | aminoacyl-tRNA ligase activity | 8.33% (5/60) | 4.44 | 3e-06 | 3.1e-05 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 8.33% (5/60) | 4.44 | 3e-06 | 3.1e-05 |
GO:0006520 | cellular amino acid metabolic process | 10.0% (6/60) | 3.51 | 1.3e-05 | 0.000133 |
GO:0140101 | catalytic activity, acting on a tRNA | 8.33% (5/60) | 3.95 | 1.6e-05 | 0.000156 |
GO:0006399 | tRNA metabolic process | 8.33% (5/60) | 3.66 | 4.3e-05 | 0.000405 |
GO:0003674 | molecular_function | 65.0% (39/60) | 0.72 | 5.2e-05 | 0.000405 |
GO:0043436 | oxoacid metabolic process | 10.0% (6/60) | 3.16 | 5.2e-05 | 0.000418 |
GO:0019752 | carboxylic acid metabolic process | 10.0% (6/60) | 3.16 | 5.2e-05 | 0.000418 |
GO:0006082 | organic acid metabolic process | 10.0% (6/60) | 3.16 | 5.2e-05 | 0.000418 |
GO:0003723 | RNA binding | 10.0% (6/60) | 3.19 | 4.7e-05 | 0.000419 |
GO:0016874 | ligase activity | 8.33% (5/60) | 3.57 | 5.9e-05 | 0.000443 |
GO:0003676 | nucleic acid binding | 20.0% (12/60) | 1.87 | 8e-05 | 0.000579 |
GO:0006139 | nucleobase-containing compound metabolic process | 18.33% (11/60) | 1.9 | 0.000135 | 0.000949 |
GO:0090304 | nucleic acid metabolic process | 16.67% (10/60) | 2.02 | 0.000144 | 0.000954 |
GO:0034660 | ncRNA metabolic process | 8.33% (5/60) | 3.3 | 0.000143 | 0.000978 |
GO:0016070 | RNA metabolic process | 15.0% (9/60) | 2.14 | 0.000178 | 0.001145 |
GO:0006725 | cellular aromatic compound metabolic process | 18.33% (11/60) | 1.79 | 0.000261 | 0.001508 |
GO:0046483 | heterocycle metabolic process | 18.33% (11/60) | 1.8 | 0.000257 | 0.00152 |
GO:0009982 | pseudouridine synthase activity | 3.33% (2/60) | 6.25 | 0.000254 | 0.001542 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 3.33% (2/60) | 6.25 | 0.000254 | 0.001542 |
GO:0140098 | catalytic activity, acting on RNA | 8.33% (5/60) | 3.09 | 0.000284 | 0.001595 |
GO:0043167 | ion binding | 30.0% (18/60) | 1.24 | 0.000309 | 0.001695 |
GO:0044281 | small molecule metabolic process | 11.67% (7/60) | 2.38 | 0.000359 | 0.001921 |
GO:1901360 | organic cyclic compound metabolic process | 18.33% (11/60) | 1.74 | 0.000371 | 0.001941 |
GO:0006325 | chromatin organization | 5.0% (3/60) | 4.37 | 0.000382 | 0.001954 |
GO:0001522 | pseudouridine synthesis | 3.33% (2/60) | 5.44 | 0.000876 | 0.004285 |
GO:0003678 | DNA helicase activity | 3.33% (2/60) | 5.44 | 0.000876 | 0.004285 |
GO:0032991 | protein-containing complex | 11.67% (7/60) | 2.11 | 0.001118 | 0.005354 |
GO:0016866 | intramolecular transferase activity | 3.33% (2/60) | 5.25 | 0.001163 | 0.005452 |
GO:0034641 | cellular nitrogen compound metabolic process | 18.33% (11/60) | 1.52 | 0.001292 | 0.005932 |
GO:0008094 | DNA-dependent ATPase activity | 3.33% (2/60) | 5.08 | 0.001489 | 0.006701 |
GO:0017111 | nucleoside-triphosphatase activity | 8.33% (5/60) | 2.45 | 0.002139 | 0.009435 |
GO:0016462 | pyrophosphatase activity | 8.33% (5/60) | 2.4 | 0.002495 | 0.010797 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 8.33% (5/60) | 2.37 | 0.002729 | 0.011586 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 8.33% (5/60) | 2.34 | 0.002978 | 0.01241 |
GO:0016043 | cellular component organization | 6.67% (4/60) | 2.71 | 0.003202 | 0.013099 |
GO:0003743 | translation initiation factor activity | 3.33% (2/60) | 4.44 | 0.003685 | 0.014807 |
GO:0071840 | cellular component organization or biogenesis | 6.67% (4/60) | 2.55 | 0.00478 | 0.018867 |
GO:0003924 | GTPase activity | 5.0% (3/60) | 3.05 | 0.00558 | 0.021646 |
GO:0031369 | translation initiation factor binding | 1.67% (1/60) | 7.25 | 0.006583 | 0.022106 |
GO:0004827 | proline-tRNA ligase activity | 1.67% (1/60) | 7.25 | 0.006583 | 0.022106 |
GO:0046040 | IMP metabolic process | 1.67% (1/60) | 7.25 | 0.006583 | 0.022106 |
GO:0006189 | 'de novo' IMP biosynthetic process | 1.67% (1/60) | 7.25 | 0.006583 | 0.022106 |
GO:0006419 | alanyl-tRNA aminoacylation | 1.67% (1/60) | 7.25 | 0.006583 | 0.022106 |
GO:0006433 | prolyl-tRNA aminoacylation | 1.67% (1/60) | 7.25 | 0.006583 | 0.022106 |
GO:0006188 | IMP biosynthetic process | 1.67% (1/60) | 7.25 | 0.006583 | 0.022106 |
GO:0004813 | alanine-tRNA ligase activity | 1.67% (1/60) | 7.25 | 0.006583 | 0.022106 |
GO:0004386 | helicase activity | 3.33% (2/60) | 4.08 | 0.006092 | 0.023234 |
GO:0009451 | RNA modification | 3.33% (2/60) | 3.93 | 0.007502 | 0.024823 |
GO:0008135 | translation factor activity, RNA binding | 3.33% (2/60) | 3.85 | 0.008257 | 0.026166 |
GO:0045182 | translation regulator activity | 3.33% (2/60) | 3.85 | 0.008257 | 0.026166 |
GO:0090079 | translation regulator activity, nucleic acid binding | 3.33% (2/60) | 3.85 | 0.008257 | 0.026166 |
GO:0140097 | catalytic activity, acting on DNA | 3.33% (2/60) | 3.79 | 0.009044 | 0.028264 |
GO:0044237 | cellular metabolic process | 21.67% (13/60) | 1.01 | 0.010122 | 0.031197 |
GO:1990904 | ribonucleoprotein complex | 3.33% (2/60) | 3.66 | 0.010716 | 0.032581 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0000228 | nuclear chromosome | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0003725 | double-stranded RNA binding | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0016743 | carboxyl- or carbamoyltransferase activity | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0016597 | amino acid binding | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0016593 | Cdc73/Paf1 complex | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0009123 | nucleoside monophosphate metabolic process | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0001671 | ATPase activator activity | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0005956 | protein kinase CK2 complex | 1.67% (1/60) | 6.25 | 0.013123 | 0.032806 |
GO:0005515 | protein binding | 13.33% (8/60) | 1.38 | 0.010966 | 0.032897 |
GO:0032550 | purine ribonucleoside binding | 5.0% (3/60) | 2.44 | 0.017721 | 0.040685 |
GO:0005525 | GTP binding | 5.0% (3/60) | 2.44 | 0.017721 | 0.040685 |
GO:0032549 | ribonucleoside binding | 5.0% (3/60) | 2.44 | 0.017721 | 0.040685 |
GO:0001882 | nucleoside binding | 5.0% (3/60) | 2.44 | 0.017721 | 0.040685 |
GO:0001883 | purine nucleoside binding | 5.0% (3/60) | 2.44 | 0.017721 | 0.040685 |
GO:0032561 | guanyl ribonucleotide binding | 5.0% (3/60) | 2.44 | 0.017721 | 0.040685 |
GO:0030234 | enzyme regulator activity | 3.33% (2/60) | 3.34 | 0.016468 | 0.040717 |
GO:0006354 | DNA-templated transcription, elongation | 1.67% (1/60) | 5.66 | 0.01962 | 0.040875 |
GO:0031406 | carboxylic acid binding | 1.67% (1/60) | 5.66 | 0.01962 | 0.040875 |
GO:0019887 | protein kinase regulator activity | 1.67% (1/60) | 5.66 | 0.01962 | 0.040875 |
GO:0019207 | kinase regulator activity | 1.67% (1/60) | 5.66 | 0.01962 | 0.040875 |
GO:0043177 | organic acid binding | 1.67% (1/60) | 5.66 | 0.01962 | 0.040875 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.67% (1/60) | 5.66 | 0.01962 | 0.040875 |
GO:0000439 | transcription factor TFIIH core complex | 1.67% (1/60) | 5.66 | 0.01962 | 0.040875 |
GO:0008023 | transcription elongation factor complex | 1.67% (1/60) | 5.66 | 0.01962 | 0.040875 |
GO:0005681 | spliceosomal complex | 1.67% (1/60) | 5.66 | 0.01962 | 0.040875 |
GO:0006807 | nitrogen compound metabolic process | 20.0% (12/60) | 0.96 | 0.017482 | 0.042755 |
GO:0019001 | guanyl nucleotide binding | 5.0% (3/60) | 2.39 | 0.019442 | 0.044186 |
GO:0005737 | cytoplasm | 3.33% (2/60) | 3.08 | 0.023258 | 0.048009 |